Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NK Cells, Tumor Infiltrating Lymphocytes and Cell Cytotoxicity in Renal Cell Cancer - Observational Study

NCT04377113 is registered in ClinicalTrials.gov with Clinical Hospital Center Rijeka as lead sponsor.

NCT NCT04377113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04377113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NK Cells, Tumor Infiltrating Lymphocytes and Cell Cytotoxicity in Renal Cell Cancer - Observational Study
Lead sponsor
Clinical Hospital Center Rijeka
Phase
Observational
Overall status
Completed
Start date
May 24, 2020
Completion date
July 26, 2021
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer, nk cell cytokine production, nk cell mediated immunity